State Street’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $213M | Buy |
|
|||||
|
2025
Q2 | $119M | Sell |
|
|||||
|
2025
Q1 | $128M | Sell |
|
|||||
|
2024
Q4 | $134M | Sell |
|
|||||
|
2024
Q3 | $216M | Buy |
|
|||||
|
2024
Q2 | $136M | Sell |
|
|||||
|
2024
Q1 | $88.3M | Buy |
|
|||||
|
2023
Q4 | $31.1M | Sell |
|
|||||
|
2023
Q3 | $26.5M | Sell |
|
|||||
|
2023
Q2 | $68.6M | Buy |
|
|||||
|
2023
Q1 | $67.2M | Buy |
|
|||||
|
2022
Q4 | $79.2M | Buy |
|
|||||
|
2022
Q3 | $28.7M | Sell |
|
|||||
|
2022
Q2 | $26.7M | Buy |
|
|||||
|
2022
Q1 | $30.3M | Buy |
|
|||||
|
2021
Q4 | $33.2M | Sell |
|
|||||
|
2021
Q3 | $35.2M | Buy |
|
|||||
|
2021
Q2 | $33.2M | Sell |
|
|||||
|
2021
Q1 | $29.4M | Buy |
|
|||||
|
2020
Q4 | $17.4M | Buy |
|
|||||
|
2020
Q3 | $6.88M | Buy |
|